NEOIMMUNE
Universal Medicine is a technology developer in the field of immune system, dedicated to the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment, focusing on technology developers in the field of immune system . Recently announced the completion of a 30 million RMB Pre-A round of strategic financing. WinX Capital is acting as a financial advisor. This round of investment was initi... ated by Kangsheng Global. Ruijiang Kangsheng Fund managed by Ruijiang Investment led the investment. The investors included Spark Venture Capital and Yangtze River Source Fund. This round of funds will be mainly used for the promotion of hematological tumor MRD products and the research and development of new clinical products.
NEOIMMUNE
Industry:
Biotechnology Health Care Medical
Founded:
2019-12-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.neoimmune.cn
Total Employee:
11+
Status:
Active
Contact:
+86 0755-32960061
Total Funding:
30 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro Pound Sterling Japanese Yen
Current Employees Featured
Investors List
Spark Ventures
Spark Ventures investment in Seed Round - NeoImmune
Kindstar Global (Beijing) Medicine Technology
Kindstar Global (Beijing) Medicine Technology investment in Seed Round - NeoImmune
Official Site Inspections
http://www.neoimmune.cn
- Host name: 118.178.127.177
- IP address: 118.178.127.177
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "NeoImmune"
泛因医学-Neoimmune
Neoimmune . 1.高新技术企业2.深圳市创新型中小企业3.2023广东省名优高新产品 . Read More . 联系我们. 深圳市龙岗区甘李路3号恒特美大厦A座8楼807； 深圳市龙岗区甘李五路1号科伦特研 …See details»
NeoImmune泛因医学 - NeoImmune, NGS, Fanyin, fanyinyixue, …
Tel：0755-84534802；E-mail：[email protected]. Some website images are sourced from the internet. If you have any copyright issues, please contact us to delete them. Guangdong …See details»
NeoImmune - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +86 0755-32960061 Universal Medicine is a technology developer in the field of immune system, …See details»
NeoImmune 2025 Company Profile: Valuation, Funding
NeoImmune General Information Description. Developer of industry leading reagents designed for minimal residual disease (MRD) testing. The company specializes in key technologies for high …See details»
Shenzhen Neoimmune Co Ltd.: Drug pipelines, Patents, Clinical …
Aug 26, 2023 Explore Shenzhen Neoimmune Co Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Shenzhen Neoimmune Co Ltd.:Company Profile & Technical …
Shenzhen Neoimmune Co Ltd. is headquartered in China Guangdong Sheng. Shenzhen Neoimmune Co Ltd. was founded in 2019. Shenzhen Neoimmune Co Ltd. has a total of 8 patentsSee details»
Neoimmune - Company Profile - Tracxn
Feb 25, 2025 Neoimmune - Provider of immunodiagnosis platform for the detection of tumors. Raised a total funding of $4.69M over 2 rounds from 3 investors. JavaScript is disabled in your …See details»
泛因医学 | 项目信息-36氪
深圳泛因医学有限公司致力于开发高通量读写T和B淋巴细胞受体谱的关键技术及其在临床检测和治疗方面应用，专注于免疫系统领域的技术研发商。泛因医学是国内领先的免疫组学技术平台型公司，创始团队发表了国内第一篇白血病NGS …See details»
公司简介 - neoimmune.cn
泛因医学简介. 泛因医学是一家在免疫学精准医疗领域提供数据和技术的平台供应商，先后获得 深圳市创新型中小企业、 国家高新技术企业、深圳市专精特新中小企业认定。. 依托免疫组 …See details»
NeoImmune company information, funding & investors
NeoImmune, . Here you'll find information about their funding, investors and team.See details»
泛因医学产品 - neoimmune.com.cn
深圳泛因医学有限公司是一家致力于开发高通量读写t和b淋巴细胞受体谱的关键技术及其在临床检测和治疗方面应用的高科技 ...See details»
公司资质 - NeoImmune
Powered by MetInfo 7.9 ©2008-2025 mituo.cn 公司资质 2021年3月，由泛因医学自主研发的血液肿瘤MRD检测产品NEO-MRD获得了欧盟CE准入资质。See details»
Profile-NeoImmune泛因医学
Introduction to Shenzhen Neoimmune Co., Ltd Shenzhen Neoimmune Co., Ltd is a platform provider that provides data and technology in the field of immunology precision medicine and …See details»
Neoimmune - 2025 Funding Rounds & List of Investors - Tracxn
May 5, 2025 Neoimmune has raised a total funding of $4.69M over 2 rounds from 3 investors. Investors include Ruijiang, Kindstar and 1 other. Their latest funding round was of $4.69M on …See details»
News-NeoImmune泛因医学
Nov 25, 2021 Tel：0755-84534802；E-mail：[email protected]. Some website images are sourced from the internet. If you have any copyright issues, please contact us to delete them. …See details»
NeoImmune - Funding, Financials, Valuation & Investors
NeoImmune is a developer of technologies for the reading and writing of T and B lymphocyte receptor repertoire and its medical applications. New. Resources. ... How much funding has …See details»
Shenzhen Neoimmune and Maijie Medical reached a strategic …
Shenzhen Neoimmune Co., Ltd has long been rooted in the field of hematological tumors, mainly engaged in the treatment of leukemia, lymphoma and other diseases, monitoring and …See details»
企业文化 - neoimmune.cn
量化免疫，护航健康 "量化免疫，护航健康"是泛因一贯以来坚持的的原则和宗旨。 免疫的本质是清除机体内不利的因素，几乎所有的疾病进程均与免疫系统相关，但是如何深入研究免疫，在数 …See details»
Shenzhen Neoimmune Co., Ltd announced the completion of tens …
On November 25, 2021, clinical immunology diagnosis and treatment enterprise Shenzhen Neoimmune Co., Ltd announced the completion of tens of millions of RMB in PreA financing. …See details»
创始团队 - NeoImmune
电话：0755-84534802；邮箱：[email protected]. 粤ICP备20019426号-1. 部分网站图片来源于互联网，如有版权问题请联系我们删除. Powered by ...See details»